The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Distinct Antitumor Properties of a Type IV Collagen Domain Derived from Basement Membrane
Open accessAbstract
Vascular basement membrane is an important structural component of blood vessels. During angiogenesis this membrane undergoes many alterations and these changes are speculated to influence the formation of new capillaries. Type IV collagen is a major component of vascular basement membrane, and recently we identified a fragment of type IV collagen alpha2 chain with specific anti-angiogenic properties (Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., and Kalluri, R. (2000) J. Biol. Chem. 275, 1209-1215). In the present study we characterize two different antitumor activities associated with the noncollagenous 1 (NC1) domain of the alpha3 chain of type IV collagen. This domain was previously discovered to possess a C-terminal peptide sequence (amino acids 185-203) that inhibits melanoma cell proliferation (Han, J., Ohno, N., Pasco, S., Monboisse, J. C., Borel, J. P., and Kefalides, N. A. (1997) J. Biol. Chem. 272, 20395-20401). In the present study, we identify the anti-angiogenic capacity of this domain using several in vitro and in vivo assays. The alpha3(IV)NC1 inhibited in vivo neovascularization in matrigel plug assays and suppressed tumor growth of human renal cell carcinoma (786-O) and prostate carcinoma (PC-3) in mouse xenograft models associated with in vivo endothelial cell-specific apoptosis. The anti-angiogenic activity was localized to amino acids 54-132 using deletion mutagenesis. This anti-angiogenic region is separate from the 185-203 amino acid region responsible for the antitumor cell activity. Additionally, our experiments indicate that the antitumor cell activity is not realized until the peptide region is exposed by truncation of the alpha3(IV)NC1 domain, a requirement not essential for the anti-angiogenic activity of this domain. Collectively, these results effectively highlight the distinct and unique antitumor properties of the alpha3(IV)NC1 domain and the potential use of this molecule for inhibition of tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
O'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Folkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Caspases: Intracellular Signaling by Proteolysis
Salvesen, G. S., & Dixit, V. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80430-4 · Cited by 2,117
COLLAGENS: Molecular Biology, Diseases, and Potentials for Therapy
Prockop, D. J., & Kivirikko, K. I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002155 · Cited by 1,623
Wyllie, A. H., Morris, R. G., Smith, A. L., & Dunlop, D. (1984) · The Journal of Pathology · doi:10.1002/path.1711420112 · Cited by 1,555
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
Dawson, D. W., Volpert, O. V., Gillis, P., Crawford, S. E., Xu, H.-J., Benedict, W., & Bouck, N. P. (1999) · Science · doi:10.1126/science.285.5425.245 · Cited by 1,505
Anti-Angiogenesis: New Concept for Therapy of Solid Tumors
Folkman, J. (1972) · Annals of Surgery · doi:10.1097/00000658-197203000-00014 · Cited by 1,171
A Network Model for the Organization of Type IV Collagen Molecules in Basement Membranes
TIMPL, R., WIEDEMANN, H., DELDEN, V., FURTHMAYR, H., & KUHN, K. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb05690.x · Cited by 897
Passaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
Macromolecular organization of basement membranes
Timpl, R. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80102-5 · Cited by 665
Hudson, B. G., Reeders, S. T., & Tryggvason, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74270-7 · Cited by 623
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Casciola-Rosen, L., Nicholson, D. W., Chong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K., & Rosen, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1957 · Cited by 613
Basement Membrane Proteins: Structure, Assembly, and Cellular Interactions
M, M. P. (1992) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239209082560 · Cited by 602
Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth
Kamphaus, G. D., Colorado, P. C., Panka, D. J., Hopfer, H., Ramchandran, R., Torre, A., Maeshima, Y., Mier, J. W., Sukhatme, V. P., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1209 · Cited by 475
Self-citationAnti-angiogenic cues from vascular basement membrane collagen.
Colorado, P. C., Torre, A., Kamphaus, G. D., Maeshima, Y., Hopfer, H., Takahashi, K., Volk, R., Zamborsky, E. D., Herman, S., Sarkar, P. K., et al. (2000) · PubMed · Cited by 426
Self-citationEarly Detection of Apoptosis Using a Fluorescent Conjugate of Annexin V
Zhang, G., Gurtu, V., Kain, S. R., & Yan, G. (1997) · BioTechniques · doi:10.2144/97233pf01 · Cited by 387
Ray, J., & Stetler-Stevenson, W. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112062 · Cited by 359
Removal of Endotoxin from Recombinant Protein Preparations
Liu, S., Tobias, R., McClure, S., Styba, G., Shi, Q., & Jackowski, G. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00049-0 · Cited by 332
Kalluri, R., Shield, C. F., Todd, P., Hudson, B. G., & Neilson, E. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119431 · Cited by 319
Self-citationAntiangiogenic Activity of Restin, NC10 Domain of Human Collagen XV: Comparison to Endostatin
Ramchandran, R., Dhanabal, M., Volk, R., Waterman, M. J. F., Segal, M., Lu, H., Knebelmann, B., & Sukhatme, V. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0248 · Cited by 290
Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma.
Dhanabal, M., Ramchandran, R., Volk, R., Stillman, I. E., Lombardo, M., Iruela‐Arispe, M. L., Simons, M., & Sukhatme, V. P. (1999) · PubMed · Cited by 240
Self-citationTurner, N., Mason, P. J., Brown, R., Fox, M., Povey, S., Rees, A., & Pusey, C. D. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115625 · Cited by 220
Endothelial cell-matrix interactions: in vitro models of angiogenesis.
Madri, J. A., & Pratt, B. M. (1986) · Journal of Histochemistry & Cytochemistry · doi:10.1177/34.1.2416801 · Cited by 207
Yoshiji, H., Harris, S. R., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 206
Netzer, K.-O., Leinonen, A., Boutaud, A., Borza, D.-B., Todd, P., Gunwar, S., Langeveld, J. P. M., & Hudson, B. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11267 · Cited by 192
Vernon, R. B., Lara, S. L., Drake, C. J., Iruela‐Arispe, M. L., Angello, J. C., Little, C. D., Wight, T. N., & Sage, E. H. (1995) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02633972 · Cited by 143
Growth-Regulatory Factors for Normal, Premalignant, and Malignant Human Cells In Vitro
Herlyn, M., Kath, R., Williams, N. N., Valyi-Nagy, I. T., & Rodeck, U. (1990) · Advances in cancer research · doi:10.1016/s0065-230x(08)60812-x · Cited by 118
SIEBOLD, B., Deutzmann, R., & Kühn, K. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14321.x · Cited by 107
Hellmark, T., Burkhardt, H., & Wieslander, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25862 · Cited by 104
A Cell Binding Domain from the α3 Chain of Type IV Collagen Inhibits Proliferation of Melanoma Cells
Han, J., Ohno, N., Brassart‐Pasco, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20395 · Cited by 93
Shahan, T. A., Ziaie, Z., Brassart‐Pasco, S., Fawzi, A., Bellon, G., Monboisse, J. C., & Kefalides, N. A. (1999) · PubMed · Cited by 82
Haralabopoulos, G. C., Ds, G., Hk, K., Pi, L., Sp, P., & Me, M. (1994) · PubMed · Cited by 79
The Role of Basement Membrane in Angiogenesis and Tumor Growth
Grant, D. S., Kibbey, M. C., Kinsella, J. L., et al. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80989-1 · Cited by 66
Extracellular matrix modulation of vascular cell behaviour
Madri, J. A. (1997) · Transplant Immunology · doi:10.1016/s0966-3274(97)80035-4 · Cited by 59
Zhang, X., Hudson, B. G., & Sarras, M. P. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1176 · Cited by 59
Maragoudakis, M. E., Missirlis, E., Karakiulakis, G., Sarmonica, M., Bastakis, M., & Tsopanoglou, N. E. (1993) · Kidney International · doi:10.1038/ki.1993.24 · Cited by 55
Tsilibary, E. C., Reger, L. A., Vogel, A. M., Koliakos, G., Anderson, S. S., CHARONIS, A. S., Alegre, J. N., & Furcht, L. T. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.4.1583 · Cited by 50
Regulation of survival and death of mesangial cells by extracellular matrix
Sugiyama, H., Kashihara, N., Maeshima, Y., Okamoto, K., Kanao, K., Sekikawa, T., & Makino, H. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00116.x · Cited by 48
Self-citation(1998) · doi:10.1002/(sici)1097-0320(19980101)31:1<1::aid-cyto1>3.0.co;2-r
Cited by
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Basement membranes: structure, assembly and role in tumour angiogenesis
Kalluri, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1094 · Cited by 1,748
Self-citationAngiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Folkman, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.121304.131306 · Cited by 1,209
Ascorbic acid: Chemistry, biology and the treatment of cancer
Du, J., Cullen, J. J., & Buettner, G. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.003 · Cited by 1,070
Metadata
- Authors
- Maeshima, Y., Colorado, P. C., Torre, A., Holthaus, K. A., Grunkemeyer, J. A., Ericksen, M. B., Hopfer, H., Xiao, Y., Stillman, I. E., & Kalluri, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 28
- Pages
- 21340-21348
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2014696732
- Cited by
- 358
- References
- 47
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.